By Michelle Cherie Carr Crowe Just Call…408-252-8900Real Estate Agent with Get Results Team…Just Call (408) 252-8900! . DRE #00901962 . Licensed to Sell since 1985 . Altas Realty DRE# 00901962 Lic.1985 August 28, 2021 10:00 AM
What do Ishi and the first American Indian reservation have in common? Both share an important anniversary on August 29th.
1758 – The first American Indian reservation (now known as a Native American reservation) is established at Indian Mills, New Jersey.
1911 – Ishi, believed to be the last remaining member of the Yahi, a group of the Yana people, emerges from the wilderness of northeastern California near Oroville. Ishi is considered the last Native American to make contact with European Americans.
Ishi means “man” in the Yana language. AnthropologistAlfred Kroeber gave this name to the man because in the Yahi culture it is rude to ask a person’s name. Ishi was taken in by anthropologists at the University of California, Berkeley, who both studied him and hired him as a research assistant until his death.
Image of Ishi is originally from the University of California, Berkeley, and is in the public domain
1911 – Ishi, believed to be the last remaining member of the Yahi, a group of the Yana people, emerges from the wilderness of northeastern California near Oroville. Ishi is considered the lastNativeAmericantomakecontactwithEuropeanAmericans. Ishi means “man” in the Yana language
On August 29 in 1758 New Jersey established the first American Indian Reservation in Shamong Township, New Jersey. This was the colonies’ first attempt at creating a reservation for Native Americans. The community of Delaware Indians did not last very long. The remnants of the tribe were eventually removed to Western reservations and reservation’s church was utilized by white residents until it burned down in 1802.
** Fratelli Beretta USA, Inc., a Mount Olive, N.J. establishment, is recalling approximately 862,000 pounds of uncured antipasto products that may be contaminated with Salmonella Infantis and/or Salmonella Typhimurium, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.
The ready-to-eat (RTE) uncured antipasto meat trays were produced on February 28, 2021 through August 15, 2021. The following products are subject to recall [view labels]:
24-oz. trays containing two 12-oz packages of “Fratelli Beretta UNCURED ANTIPASTO PROSCIUTTO, SOPPRESSATA, MILANO SALAMI & COPPA” with best by dates of AUG 27 21 through FEB 11 22 and UPC code 073541305316.
The products subject to recall bear establishment number “EST. 7543B” printed on the packaging next to the best by date. These items were shipped to retail locations nationwide. Consumers with questions regarding the recall can contact Fratelli Beretta USA Inc.’s recall hotline at 1-866-918-8738. Media may contact Marco Lastrico of Barabino & Partners USA, at m.lastrico@barabinousa.com or 917-634-1685.
**
** Willow Tree Poultry Farm, an Attleboro, Mass. establishment, is recalling approximately 52,022 pounds of various chicken salads and dip products that may be contaminated with extraneous materials, specifically hard white plastic the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.
The ready-to-eat (RTE) various chicken salads and dip items were produced on August 10, 2021 through August 13, 2021. The following products are subject to recall:
5-lb container of “Willow Tree Premium White Meat Caesar Chicken Dip” with sell by dates of 09/03/2021 and 09/06/2021.
5-lb and 12-oz containers of “Willow Tree Premium White Meat Buffalo Chicken Dip” with sell by dates of 09/03/2021 and 09/05/2021.
5-lb container of “Willow Tree Premium White Meat Buffalo Chicken Salad” with a sell by date of 09/07/2021.
15-oz container of “Willow Tree Premium White Meat Buffalo Chicken Salad” with sell by dates of 09/07/2021 and 09/09/2021.
15-oz container of “Willow Tree Premium White Meat Cranberry Walnut Chicken Salad” with a sell by date of 09/08/2021.
15-oz container of “Willow Tree Premium White Meat Classic Chicken Salad” with sell by dates of 09/07/2021, 09/08/2021, 09/09/2021, 09/10/2021.
7.5-oz container of “Willow Tree Premium White Meat Classic Chicken Salad” with sell by dates of 09/07/2021 and 09/09/2021.
10-lb container of “Willow Tree Premium White Meat Classic Chicken Salad” with a sell by date of 09/08/2021.
The products subject to recall bear establishment number “EST. P-8827” inside the USDA mark of inspection. These items have been shipped to wholesale and retail locations in Connecticut, Massachusetts, Maine, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont.
** Avanti Frozen Foods Pvt. Ltd, is voluntarily expanding a prior recall issued on June 25,2021 to include certain consignments of various sizesof frozen cooked, peeled, deveined, shrimp (with some packaged with cocktail sauce) sold in various unit sizes, because it has the potential to be contaminated with Salmonella. The frozen shrimp products were distributed nationwide from November 2020 to May 2021.
This recall expansion has been initiated out of an abundance of precaution and will cover a large amount of product that has not been associated with any illness but been undertaken following discussions with FDA and CDC and reflects Avanti’s commitment to Public health and safety.
Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.
The affected product details in the expansion are as below
Product Description
Unit Size
Container Description
Storage Instructions
Code
Expiration Date
BIG RIVER, Frozen Cooked Peeled and Deveined Tail Off Shrimps IQF
2 LB
Printed Polythene Pouch
Frozen
10.02.2022, 10.03.2022, 10.05.2022
10/02/2022, 10/03/2022, 10/05/2022
365, Frozen Cooked Peeled and Deveined Tail On Shrimps IQF
WELLSLEYFARMS, Frozen Cooked Peeled and Deveined Tail On Shrimps IQF with Cocktail Sauce
40 OZ.
Polythene Trays
Frozen
91AS/01HN/184A, 91AS/04HN/187E
09/30/2023, 10/03/2022
WFNOBRANDS, Frozen Cooked Peeled and Deveined Tail On Shrimps IQF with Cocktail Sauce
40 OZ.
Polythene Trays
Frozen
91AS/31YN/275, 91AS/01TP/276
06/30/2022, 07/01/2023
HANNAFORD,Frozen Cooked Peeled and Deveined Tail On Shrimps IQF
1 LB
Printed Polythene Pouch
Frozen
AVF 00721 EF, AVF 00821 EF, AVF 00921 EF
12/28/2022, 12/29/2022, 12/30/2022
FOODLION,Frozen Cooked Peeled and Deveined Tail On Shrimps IQF
1 LB
Printed Polythene Pouch
Frozen
AVF 00821 EF, AVF 00921 EF, AVF 01021 EF
12/29/2022, 12/30/2022, 12/31/2022
Products not bearing these codes are not affected by or involved in this recall. There have been 9 reports of Salmonella-related illness to date associated with these cooked shrimp distributions. The company has taken several preventive steps and initiatives to eliminate potential for future contaminations.
Consumers who have purchased the above product are urged not to consume the recalled product and to return them to the place of purchase. Consumers with questions may contact the company at +914023310260/+914023310261, Mon – Fri :10:00 am – 5:00 PM , GMT+5.5.
** 8/14/2021, Mai Cuisine Inc., of Allentown, PA is voluntarily recalling 67 packs of 12pc Shrimp Tempura Kabuki Roll WR purchased in the state of California only in relation to the Shrimp recall expansion initiated by Avanti Frozen Foods Pvt. Ltd, due to potential salmonella contamination in frozen shrimp
The products are packed in clear lid containers, with labels indicating the product name, ingredients and best by date. The products can be identified with the Hand-Crafted date of 8/12/2021 and 8/13/2021 and Best By Date of 08/13/2021 and 08/14/2021 and the following UPCs:
12pc Shrimp Tempura Kabuki Roll WR UPC 8 4003140626 2.
Products were sold from Mai Sushi counters inside Target stores in northern California at the following locations:
Store Name
Address
T2767 Oakland-Emeryville
1555 40th Street, Emeryville, CA 94608
T2829 Alameda
2700 Fifth Street, Alameda, CA 94501
T3201 San Francisco CBD East
225 Bush St, San Francisco, CA 94104
T2766 San Francisco Central
789 Mission St, San Francisco, CA 94103
T3267 Berkeley Univ Ave
1414 University Ave, Berkeley, CA 94702
T3202 Berkeley Central
2187 Shattuck Ave, Berkeley, CA 94704
T3240 Marin City
180 Donahue St, Sausalito, CA 94965
T3297 SF Folsom and 13th St
1690 Folsom St, San Francisco, CA 94103
T3330 Oakland Broadway & 27th
2650 Broadway, Oakland, CA 94612
T3353 Daly City Westlake
100 Westlake Center, Daly City, CA 94015
T1926 Albany
1057 Eastshore Hwy, Albany, CA 94710
T1122 San Mateo Fashion Island
2220 Bridgepointe Pkwy, San Mateo, CA 94404
T1054 Tanforan
1150 El Camino Real, San Bruno, CA 94066
T1407 Daly City Serramonte
133 Serramonte Ctr, Daly City, CA 94015
T0320 Colma
5001 Junipero Serra Blvd, Colma, CA 94014
T3264 San Francisco Stonestown
233 Winston Dr, San Francisco, CA 94132
No illnesses have been reported to date.
The recall was initiated after Avanti Frozen Foods Pvt. Ltd expanded their recall to a particular Lot of frozen shrimp received by Mai Sushi at some of our California locations. Although these products have shelf life of 1 day, the firm is initiating this recall to ensure customer safety.
This recall is being made with the knowledge of the U.S. Food and Drug Administration.
All affected Mai Cuisine Inc., products are intended for customers to consume immediately upon purchase and have a shelf life of 1 day. However, out of abundance of caution, to ensure the safety of our customers, Mai Cuisine Inc., has initiated this voluntary recall. Consumers who have purchased this item from Mai Sushi Counters in the above mentioned stores are urged to dispose the product and contact (484) 223-4502External Link Disclaimer for a full refund.
** Houston, Texas, eBay Seller ID: jongu 4308 is voluntarily recalling all lots of Hydro Pineapple Burn to consumer level. FDA analysis has found the product to contain undeclared sibutramine. Sibutramine was an FDA approved drug used as an appetite suppressant for weight loss but was withdrawn from the market because of safety issues. The presence of sibutramine in Hydro Pineapple Burn renders it an unapproved drug for which safety and efficacy has not been established and therefore subject to recall. To date, jongu 4308 has not receive any report of adverse events related to this recall
Risk Statement: product containing sibutramine pose a health risk to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
This tainted product is marketed as a dietary supplement for weigh losst and is packaged in a box containing ten 20g sachets. Hydro Pineapple Burn was distributed by eBay via internet at www.ebay.comExternal Link Disclaimer nationwide in the USA (from 05/29/2021 to 07/27/2021). On August 03, 2021, FDA issued a press release that warned consumers to avoid certain products found eBay, Amazon, and other retailers due to hidden and potentially dangerous drug ingredients. It also encouraged online marketplaces to ensure these products are not sold on their platforms.
eBay Seller ID: jongu 4308 is notifying its customers by this press announcement and via e-mail of this recall. Consumers that have Hydro Pineapple Burn, which is being recalled should stop using and destroy them. Consumers with questions regarding this recall can contact eBay Seller ID: jongu 4308 by messaging on eBbay or email: johnnyvn100@yahoo.com. Consumers should contact their physicians or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
** 8/14/2021, Mai Franchising Inc., of Allentown, PA is voluntarily recalling 103 packs of sushi containing cocktail shrimp for products purchased in the state of California only.in relation to the Shrimp recall expansion initiated by Avanti Frozen Foods Pvt. Ltd, due to potential salmonella contamination in frozen shrimp.
The products are packed in clear lid containers, with labels indicating the product name, ingredients and best by date. The products can be identified with the Hand-Crafted date of 8/12/2021 and 8/13/2021 and Best By Date of 08/13/2021 and 08/14/2021 and the following UPCs:
Name
UPC
SPICY SHRIMP TEMPURA ROLL
81282401109
SPECIAL ROLL SUPER SET 16PC
81282401129
CHEF’S ASSORTED NIGIRI 6PC
81282401130
SCORPION ROLL
81282401138
BR SPECIAL ROLL SUPER SET 16PC
81282401203
COOKED VARIETY PACK
81282401349
SHRIMP MANGO FRESH ROLL
81282401374
Products were sold from Mai Sushi counters inside New Leaf Community Market stores in northern California at the following locations:
Store Name
Address
New Leaf Market – Capitola
1210 41st Avenue, Capitola, CA 95010
New Leaf Market – Evergreen
5667 Silver Creek Valley Road, San Jose, CA 95138
New Leaf Market – Halfmoon Bay
150 San Metro Road, half Moon Bay, CA 94019
New Leaf Market – Pacific
1134 Pacific Avenue, Santa Cruz, CA 95060
New Leaf Market – Santa Cruz
1101 Fair Avenue, Santa Cruz, CA 95060
The recall was initiated after Avanti Frozen Foods Pvt. Ltd expanded their recall to a particular Lot of frozen shrimp received by Mai Sushi at some of our California locations. Although these products have shelf life of 1 day, the firm is initiating this recall to ensure customer safety.
This recall is being made with the knowledge of the U.S. Food and Drug Administration
All affected Mai Franchising LLC., products are intended for customers to consume immediately upon purchase and have a shelf life of 1 day. However, out of abundance of caution, to ensure the safety of our customers, Mai Franchising LLC., has initiated this voluntary recall. Consumers who have purchased these items from Mai Sushi Counters in the above mentioned stores are urged to dispose the product and contact (484) 223-4502External Link Disclaimer for a full refund.
** Hostess Brands, LLC (“Hostess Brands”) is voluntarily recalling certain Hostess® Soft White Hamburger Buns and Soft White Hot Dog Buns due to the potential for the products to be contaminated with Listeria monocytogenes and Salmonella. Hostess Brands is recalling the impacted products out of an abundance of caution after becoming aware of this issue from its co-manufacturer, Best Harvest Bakeries, through Best Harvest Bakeries’ environmental monitoring program. To date, Hostess Brands has received no reports of illness related to this issu
Listeria monocytogenes is an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.
Salmonella is an organism that can cause serious and sometimes fatal infections in young children, elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses.
This recall is limited to the following Hostess® Soft White Hamburger Buns and Soft White Hot Dog Buns, which were sold to distributors, convenience stores, and other retail stores throughout the United States:
As Best Harvest Bakeries only manufactures certain Hostess® hamburger buns and hot dog buns for Hostess Brands, no other Hostess® products are affected, including Hostess® bread and bagel products.
Consumers who have purchased an affected product are urged to immediately dispose of the product or return it to the place of purchase for a full refund.
** Hanford, California, Je Dois L’avoir Boutique is voluntarily recalling all of the 365 Skinny High Intensity Pills and or 365 Skinny Emergency Boutique, 30 day capsules supply to the retail/consumer level. The 365 Skinny High Intensity Pills and 365 Skinny Emergency Boutique have been found to contain Sibutramine which is a controlled substance by the DEA and poses significant health risks to consumers both products are from the same manufacturer 365 Skinny is the strongest form and the 365 Skinny Emergency is for people with high blood pressure, diabetes but not limited to other chronic illnesses.
Risk Statement: The 365 Skinny High Intensity Pills and 365 Skinny Emergency Boutique potentially can cause serious health risks such as seizures, tachycardia, palpitations, heart attacks and allergic reactions. Risks associated with this product are more likely with people who have high blood pressure, thyroid disease, men or woman over 65 or children under 16 years old. Je Dois L’avoir Boutique has not received any reports of adverse events related to this recall.
The product is used together with diet and exercise to assist with weight loss and is packaged in bottles of 30 capsules 600mg per capsule.
All lots and expiration dates of any of these products are being recalled. Je Dois L’avoir is recalling ALL 365 Skinny High Intensity Pills and 365 Emergency Boutique that it has sold to the public as seen below.
Je Dois L’avoir is notifying its distributors and customers by email and is arranging for return/replacement etc. of all recalled products. Consumers that have 365 High Intensity Skinny or 365 Skinny Emergency Boutique which is being recalled should stop using/return to place of purchase/discard/contact Je Dois L’avoir Boutique Immediately at 559-302-6215.
Consumers with questions regarding this recall can contact Je Dois L’avoir Boutique by phone Monday-Friday 9-6pm pacific standard time or email us at jedois2020@gmail.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
** Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily Intake (ADI) level.
Long-term ingestion of N-nitroso-varenicline may be associated with a theoretical potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication. The health benefits of stopping smoking outweigh the theoretical potential cancer risk from the nitrosamine impurity in varenicline.
Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time. i
Chantix is a treatment to help patients quit smoking and is intended for short term use. People who smoke cigarettes are 15 to 30 times more likely to get lung cancer than people who do not smoke. ii Smoking is also associated with many other cancers.iii CHANTIX has a safety profile that has been established over 15 years of marketing authorization and through a robust clinical program. Pfizer believes the benefit/risk profile of CHANTIX remains positive. Patients currently taking Chantix should consult with their doctor to confirm if they received an affected lot, and if appropriate, about alternative treatment options. To date, Pfizer has not received any reports of adverse events that have been related to this recall.
The NDC, Lot Number, Expiration Date, and Configuration details for Chantix Tablets is indicated in the table below with the four additional lots. Photos of the products can be found at the end of this press release. The product lots were distributed nationwide to wholesalers and Distributors in the United States and Puerto Rico from June 2019 to June 2021.
Product
NDC
Lot Number
Expiration Date
Presentation
Configuration/Count
Chantix (varenicline) Tablets, 0.5 mg
0069-0468-56
00019213
2022 JAN
Bottles
56 tablets/bottle
Chantix (varenicline) Tablets, 0.5 mg
0069-0468-56
EC6994
2023 MAY
Bottles
56 tablets/bottle
Chantix (varenicline) Tablets, 1 mg
0069-0469-56
EA6080
2023 MAR
Bottles
56 tablets/bottle
Chantix (varenicline) Tablets, 1 mg
0069-0469-56
EC9843
2023 MAR
Bottles
56 tablets/bottle
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
00018522
2021 AUG
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
00018523
2021 AUG
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
00018739
2021 AUG
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
00018740
2021 AUG
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
00020231
2021 SEP
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
00020232
2021 NOV
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
00020357
2021 DEC
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
00020358
2022 JAN
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
00020716
2022 JAN
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
ET1600
01/2023
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
ET1607
01/2023
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Chantix (varenicline) Tablets, 0.5/1 mg
0069-0471-03
ET1609
01/2023
Cartons containing 2 blister packs
Carton containing one blister pack of 11 0.5 mg tablets and one blister pack containing 42 1 mg tablets
Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process. Pfizer has notified their direct consignees by letter to arrange for return of any recalled product.
Wholesalers and distributors with an existing inventory of the lots, listed in the table above, should stop use and distribution and quarantine the product immediately.
If you have further distributed the recalled product, please notify any accounts or additional locations which may have received the recalled product from you. Please conduct a sub-recall to those accounts and communicate this recall information immediately. Please request they immediately cease distribution of the affected product and promptly contact Stericycle at 888-276-6166 (Mon.-Fri. 8:00 am – 5:00 pm ET) to obtain a Business Reply Card (BRC) to initiate the return process.
If you received free product through the Pfizer Patient Assistance Program (PAP) or the Pfizer Institutional Patient Assistance Program (IPAP), please check your stock immediately against the table above. If you have any of the affected product lots in your inventory, please follow the instructions above for returning the product to Stericycle Inc. Additionally, if you are aware of any patients to whom you dispensed the affected lots who still may have the product in their possession, please ask them to return the product to you and then follow the instructions above for returning the product to Stericycle Inc. To request replacement product for any Pfizer PAP or Pfizer IPAP product you return, please contact 833-203-2776 (Mon.-Fri. 8:00 am – 6:00 pm ET).
As communicated by FDA, there is no immediate risk to patients taking Chantix. iv Patients who are taking this product should consult with their health care provider or pharmacy to determine if they have the affected product lots. Patients with the affected lots should contact Stericycle Inc. at 888-276-6166 (Mon.-Fri. 8:00 am – 5:00 pm ET) for instructions on how to return their product and obtain reimbursement for their cost.
Healthcare Professionals with questions regarding this recall can contact Pfizer using the below information.
800-438-1985, option 1 (24 hours a day; 7 days a week)
To report adverse events and product complaints
Adverse events or product complaints experienced with the use of this product may also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
You must be logged in to post a comment.